Signaling pathways and targeted therapies for psoriasis

J Guo, H Zhang, W Lin, L Lu, J Su… - Signal Transduction and …, 2023 - nature.com
Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on
individuals, health systems, and society worldwide. With the immunological pathologies and …

Vitamin D signaling in psoriasis: pathogenesis and therapy

AA Brożyna, RM Slominski, B Nedoszytko… - International Journal of …, 2022 - mdpi.com
Psoriasis is a systemic, chronic, immune-mediated disease that affects approximately 2–3%
of the world's population. The etiology and pathophysiology of psoriasis are still unknown …

Decoding IL-23 signaling cascade for new therapeutic opportunities

G Pastor-Fernández, IR Mariblanca, MN Navarro - Cells, 2020 - mdpi.com
The interleukin 23 (IL-23) is a key pro-inflammatory cytokine in the development of chronic
inflammatory diseases, such as psoriasis, inflammatory bowel diseases, multiple sclerosis …

Unexpected connections of the IL-23/IL-17 and IL-4/IL-13 cytokine axes in inflammatory arthritis and enthesitis

C Bridgewood, D Newton, N Bragazzi… - Seminars in …, 2021 - Elsevier
Abstract The IL-23/IL-17 cytokine axis is related to spondyloarthropathy (SpA) pattern
diseases that target the skin, eye, gut and joints. These share overlapping target tissues with …

Role of epithelium-derived cytokines in atopic dermatitis and psoriasis: Evidence and therapeutic perspectives

F Borgia, P Custurone, L Peterle, G Pioggia… - Biomolecules, 2021 - mdpi.com
Atopic dermatitis and psoriasis are two of the most common chronic skin conditions. Current
target therapies represent viable and safe solutions for the most severe cases of these two …

IL-33-mediated activation of mast cells is involved in the progression of imiquimod-induced psoriasis-like dermatitis

X Zhou, Y Hu, L Liu, L Liu, H Chen, D Huang… - Cell Communication and …, 2023 - Springer
Background Psoriasis is a chronic inflammatory dermatosis with an unclear pathogenesis.
Mast cells (MCs) can serve as a bridge between innate and adaptive immunity and are …

IL-33 supplementation improves uterine artery resistance and maternal hypertension in response to placental ischemia

X Wang, C Shields, G Tardo… - American Journal …, 2024 - journals.physiology.org
Preeclampsia (PE), a leading cause of maternal/fetal morbidity and mortality, is a
hypertensive pregnancy disorder with end-organ damage that manifests after 20 wk of …

The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives

H Iznardo, L Puig - Expert Review of Clinical Immunology, 2021 - Taylor & Francis
Introduction: IL-1 family cytokines play an important role in the innate immune system and
their uncontrolled activation and expression can initiate a pathologic inflammatory response …

Epidermis-intrinsic transcription factor Ovol1 coordinately regulates barrier maintenance and neutrophil accumulation in psoriasis-like inflammation

M Dragan, P Sun, Z Chen, X Ma, R Vu, Y Shi… - Journal of Investigative …, 2022 - Elsevier
Skin epidermis constitutes the exterior barrier that protects the body from dehydration and
environmental assaults. Barrier defects underlie common inflammatory skin diseases, but …

NLRP3 inhibition improves maternal hypertension, inflammation, and vascular dysfunction in response to placental ischemia

X Wang, OK Travis, CA Shields… - American Journal …, 2023 - journals.physiology.org
Preeclampsia (PE) is a pregnancy-specific hypertensive disorder with end-organ damage
that presents after 20 wk of gestation. PE pathophysiology often includes vascular …